Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
HCAT Health Catalyst Inc
- Stocks
- Healthcare
- NASDAQ: HCAT
Price (delayed)
$3.95
Market cap
$274.92M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.15
Enterprise value
$335.32M
Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations committed to being the catalyst for massive, measurable, data-informed healthcare improvement. Its customers leverage
Highlights
HCAT's EPS is up by 38% year-on-year
The company's gross profit rose by 6% YoY
The net income has grown by 31% YoY but it has contracted by 4.5% from the previous quarter
Health Catalyst's quick ratio has decreased by 13% from the previous quarter and by 13% YoY
Key stats
What are the main financial stats of HCAT
Market
Valuations
Earnings
Shares outstanding
69.6M
Market cap
$274.92M
Enterprise value
$335.32M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.74
Price to sales (P/S)
0.87
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.08
Revenue
$311.27M
Gross profit
$140.81M
Operating income
-$67.17M
Net income
-$72.66M
EBIT
-$64.8M
EBITDA
-$18.94M
Free cash flow
-$13.89M
Per share
Balance sheet
Liquidity
EPS
-$1.15
EPS diluted
-$1.15
Free cash flow per share
-$0.2
Book value per share
$5.37
Revenue per share
$4.54
TBVPS
$6.88
Total assets
$891.54M
Total liabilities
$514.73M
Debt
$402.37M
Equity
$376.81M
Working capital
$83.16M
Debt to equity
1.07
Current ratio
1.24
Quick ratio
1.2
Net debt/EBITDA
-3.19
Margins
Efficiency
Dividend
EBITDA margin
-6.1%
Gross margin
45.2%
Net margin
-23.3%
Operating margin
-21.6%
Return on assets
-8.9%
Return on equity
-20%
Return on invested capital
-29%
Return on capital employed
-11.7%
Return on sales
-20.8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
HCAT stock price
How has the Health Catalyst stock price performed over time
Intraday
-2.23%
1 week
7.34%
1 month
-5.73%
1 year
-40.42%
YTD
-44.13%
QTD
-12.8%
Financial performance
How have Health Catalyst's revenue and profit performed over time
Revenue
$311.27M
Gross profit
$140.81M
Operating income
-$67.17M
Net income
-$72.66M
Gross margin
45.2%
Net margin
-23.3%
The operating margin rose by 44% YoY and by 5% QoQ
The operating income is up by 41% year-on-year and by 3.8% since the previous quarter
The company's net margin rose by 35% YoY but it fell by 2.6% QoQ
The net income has grown by 31% YoY but it has contracted by 4.5% from the previous quarter
Price vs fundamentals
How does HCAT's price correlate with its fundamentals
Growth
What is Health Catalyst's growth rate over time
Valuation
What is Health Catalyst stock price valuation
P/E
N/A
P/B
0.74
P/S
0.87
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.08
HCAT's EPS is up by 38% year-on-year
HCAT's price to book (P/B) is 73% lower than its 5-year quarterly average of 2.7 and 33% lower than its last 4 quarters average of 1.1
The company's equity rose by 3.2% QoQ and by 3.2% YoY
The stock's price to sales (P/S) is 81% less than its 5-year quarterly average of 4.6 and 33% less than its last 4 quarters average of 1.3
The company's revenue rose by 4.9% YoY
Efficiency
How efficient is Health Catalyst business performance
HCAT's ROS is up by 45% year-on-year and by 9% since the previous quarter
Health Catalyst's return on assets has increased by 37% YoY but it has decreased by 3.5% QoQ
HCAT's return on equity is up by 31% year-on-year but it is down by 3.6% since the previous quarter
The ROIC has contracted by 17% YoY and by 8% from the previous quarter
Dividends
What is HCAT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for HCAT.
Financial health
How did Health Catalyst financials performed over time
HCAT's total assets is 73% greater than its total liabilities
Health Catalyst's quick ratio has decreased by 13% from the previous quarter and by 13% YoY
The current ratio has contracted by 13% from the previous quarter and by 13% YoY
The company's debt is 7% higher than its equity
The debt to equity has declined by 2.7% since the previous quarter and by 2.7% year-on-year
The company's equity rose by 3.2% QoQ and by 3.2% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.